tirzepatide and fasting Efficacy Safety of for Weight Management in Non-Diabetic Obese Individuals: A Narrative Review FDA grants fast track designation

Acyl-CoA synthetase long-chain family member 4 (ACSL4), which is a key enzyme that regulates lipid composition, has been shown to contribute to the execution of ferroptosis

Dwivedi, A

GLP-1 medications are prescription-only medications and are only prescribed to type-2 diabetics and those with obesity

There were 371 investigator-reported SAEs with fatal outcome (4.21%) in the semaglutide 2.4 mg group and 460 investigator-reported SAEs with fatal outcome (5.23%) in the placebo group

Currently, there are no approved pharmacological treatments for MCI, although MCI is recognized to provide a window of opportunity to address modifiable risk factors and potentially prevent further progression to dementia [6]

In a single-arm retrospective analysis by Firkins et al., clinical outcomes in GLP-1 RA users undergoing EGD were assessed [29]